Skip to main content

Vaginal Slings Market is Increasing at a Stranded CAGR of 3.6% During Forecast to 2023


Market Overview:
Vaginal sling procedures are defined as types of surgeries that can help to control stress urinary incontinence. A new report on the global vaginal slings market, published by Market Research Future (MRFR), infers that this market could mark improvement at 3.6 % CAGR between 2017 and 2023. In terms of value, the market can be worth USD 1,459 Mn by the end of the forecast period.


Major market driving factors of the global Vaginal Slings Market Growth include the aging female population, increasing research to discover new urinary incontinence treatment options, rising occurrence of urinary incontinence. However, the complications caused by urinary incontinence surgery and various recent product recall can hinder the market growth.

Key Players:
·         A.M.I. GmbH
·         Betatech Medical
·         Boston Scientific Corporation
·         CL Medical
·         Coloplast Corp
·         Ethicon Inc
·         Herniamesh S.r.l
·         Promedon

Market Segmentation:
·         The global vaginal slings market segmentation encompasses end-user, method, and product type. MRFR’s take on the market explores various facets of the market in-depth.
·         Regarding end-users, this market has been segmented into ambulatory surgery centers, hospitals, urogynecology clinics, and others. The hospitals segment can be worth USD 539.7 Mn by 2023.
·         In the context of method, the market has been segmented into the retropubic method, single-incision mini method, and transobturator method.
·         Based on product type, the market has been segmented into mini-slings/single-incision slings, tension-free vaginal tape slings (TVT), transobturator tape slings (TOT), and others. The TVT segment holds the 52% market share in the global vaginal slings market.

Regional Segmentation:
A geographical outlining of the global vaginal slings market covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).
During the forecast period, the Americas region is expected to hold the largest market share in the global market due to the increasing awareness and the rising prevalence of urinary incontinence among the female population. Availability of advanced medical facilities in the USA and Canada is also boosting the market growth. Due to this reason, North America is the bigger regional market segment, compared to Latin America.
During the forecast period, the European market is likely to grow substantially due to increased healthcare spending and increasing awareness related to urinary incontinence issues. Due to the reasons the same as The Americas, Western Europe is a bigger regional market segment compared to Eastern Europe. Germany holds a 27% share in the market of Western Europe. Other pressing country-specific markets in this region are France, Italy, Spain, and the UK. An analysis of the remaining countries in Western Europe featured in this report estimates the huge contribution to market revenue from some other countries, along with and a sizable revenue contribution from Eastern Europe

Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...